Company Active LTD

Company profile

Edinburgh Biosciences LTD.

Edinburgh Biosciences

Edinburgh Biosciences LTD. is a UK company with status active founded in 2003 based in Scotland.

CRN
SC259295
Founded
2003
Age
22

Overview

Legal name
EDINBURGH BIOSCIENCES LTD.
Region
Scotland
Registered address
UNIT 4B GATEWAY BUSINESS PARK
BEANCROSS ROAD
GRANGEMOUTH
SCOTLAND
FK3 8WX
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
8

Company events

Reference milestones and recent Companies House filing stream events.

19 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

22 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNzUyMzQ2NGFkaXF6a2N4

Published 22 Jun 2026 08:51

22 May
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 May
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

24 Feb
2025

Second Filing Of Confirmation Statement With Made Up Date

Confirmation-statement

RP04CS01 | Transaction MzQ1NjEzNjA1NGFkaXF6a2N4

Published 24 Feb 2025 11:20

24 Feb
2025

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQ1NjAwNTc1NmFkaXF6a2N4

Published 24 Feb 2025 10:15

21 Feb
2025

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ1NTg1NjY1NWFkaXF6a2N4 | Paper/PDF filed

Published 24 Feb 2025 11:27

20 Feb
2025

Capital Allotment Shares

Capital

SH01 | Transaction MzQ1NTg1NjQ4M2FkaXF6a2N4 | Paper/PDF filed

Published 24 Feb 2025 10:15

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

01 Nov
2024

Memorandum Articles

Incorporation

MA | Transaction MzQ0MTc1Mzc5NGFkaXF6a2N4 | Paper/PDF filed

Published 02 Nov 2024 07:50

01 Nov
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURFWUNXR1lhZGlxemtjeA | Paper/PDF filed

Published 02 Nov 2024 07:44

01 Nov
2024

Notification Of A Person With Significant Control

Persons-with-significant-control

PSC01 | Transaction MzQ0MTc1NDM4NWFkaXF6a2N4

Published 01 Nov 2024 02:42

01 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MTc1Mzk3MGFkaXF6a2N4

Published 01 Nov 2024 02:32

01 Nov
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MTc1NDczMWFkaXF6a2N4

Published 01 Nov 2024 02:20

01 Nov
2024

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzQ0MTc1NDEzOGFkaXF6a2N4

Published 01 Nov 2024 02:20

02 Oct
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzODE2Mzg5MGFkaXF6a2N4

Published 02 Oct 2024 04:18

02 Oct
2024

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzQzODE2MzU1MWFkaXF6a2N4

Published 02 Oct 2024 04:13

02 Oct
2024

Notification Of A Person With Significant Control

Persons-with-significant-control

PSC01 | Transaction MzQzODE2MzUwNWFkaXF6a2N4

Published 02 Oct 2024 04:12

14 Nov
2003

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2013
Funded years
2013, 2014, 2018
Age at first award
9 years

Projects

2018 Feasibility Studies Lead participant

Assessment of Cataract Photobleaching Therapy in Animals

1 May 2018 to 31 Jul 2019

Awarded
£325,813
Total cost £465,447

As the population grows older the instances of cataract increases. This disease causes cloudiness of the lens of the eye and leads to visual impairment and blindness. Cataracts are the leading cause of blindness affecting over 51% of the global population. Accurate diagnosis is currently difficult, relying on the subjective judgement of the opthalmologist...

2014 Feasibility Studies Lead participant

Novel Method for the Detection of Aflatoxins

1 May 2014 to 30 Apr 2015

Awarded
£52,901
Total cost £70,534

Aflatoxins occur in a wide variety of foodstuffs in all parts of the world and are a major concern given their acute toxicological effects in humans. Edinburgh Biosciences Ltd and Heriot-Watt University have agreed on a collaboration to apply novel developments in spectroscopic design to investigate aflatoxins. Using the latest developments in Light Emitt...

2013 Feasibility Studies Lead participant

Novel spectroscopic measurements for agri-food systems

1 Oct 2013 to 31 Dec 2014

Awarded
£72,004
Total cost £96,108

Edinburgh Biosciences Ltd and Heriot-Watt University have agreed on a collaboration to apply novel developments in spectroscopic measurements to the agrifood sector. Narrow wavelength sources will be coupled to newly designed wedge interference filters to develop instruments allowing either rapid single wavelength measurements or wider wavelength scanning...

Product types

Feasibility Studies